Prostate cancer (PCa) remains a leading cause of mortality among men in the United States
and Western Europe. The molecular mechanism of PCa pathogenesis has not been fully …

Purpose We aimed to investigate the pathological changes, clinicopathological correlation
and prognostic factors of neoadjuvant programmed cell death 1 (PD-1) blockade …

Background Improved markers for predicting recurrence are needed to stratify patients with
localised (stage I–III) renal cell carcinoma after surgery for selection of adjuvant therapy. We …

Background: Kimura disease (KD) is a chronic benign inflammatory disorder that is usually
manifested as a deep, subcutaneous mass with or without regional lymphadenopathy in the …

Background Clear cell renal cell carcinoma (ccRCC) is a tumor that frequently shows the
hematogenous pathway and tends to be resistant to radiotherapy and chemotherapy. However, …

GPATCH3, a protein with G-patch domain, is known to participate in innate immune response
and organ development in mammals. However, there are few reports on GPATCH3 in fish. …

Background TFE3 immunohistochemistry (TFE3‐IHC) is controversial in the diagnosis of
TFE3‐rearranged renal cell carcinoma (TFE3‐rearranged RCC). This study is to investigate the …

Background. Reports about prognosis of adults receiving small pediatric-donor kidneys (PDK)
as compared to those receiving elder pediatric or adult donor kidneys (ADKs) are …

Background Considerable geometric changes to the organs at risk (OARs) have been
reported during treatment with chemotherapy and intensity modulated radiotherapy (chemo-IMRT) …

Background: Nasopharyngeal carcinoma (NPC) patients with distant metastasis have a
poor response to conventional first-line chemoradiotherapy and a poor prognosis. Growing …